Long-Term Constant Subcutaneous Drug Administration
Authors:
- 23 September 2018
- book chapter
- Published by Springer Nature
- Vol. 1868, 17-22
Abstract
In this chapter, a long-term drug delivery system for preclinical therapeutic research is introduced. By using a subcutaneously implanted ALZET® osmotic pump, continuous zero-order delivery of drugs under investigation that need repeated oral or intravenous dosing is realizable. Compared to traditional delivery systems, implanted osmotic pumps present several advantages such as that no external connections or researcher intervention is required during infusion and that it is possible to save time by eliminating the need for frequent animal handling and repetitive injection schedules. Most importantly, a stable peripheral concentration of drug is able to be obtained using this constant drug delivery system, which would benefit researchers to verify the efficiency of antirheumatoid drugs and establish safety profiles in preclinical studies.Keywords
This publication has 8 references indexed in Scilit:
- Efficacy of constant long-term delivery of YM-58483 for the treatment of rheumatoid arthritisEuropean Journal of Pharmacology, 2018
- Efficiency and Safety of CRAC Inhibitors in Human Rheumatoid Arthritis Xenograft ModelsThe Journal of Immunology, 2017
- A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritisCancer Chemotherapy and Pharmacology, 2013
- Development of ALZET® osmotic pump compatible solvent compositions to solubilize poorly soluble compounds for preclinical studiesDrug Delivery, 2012
- Accumulation of Methotrexate in Systemic Tissues after Intrathecal AdministrationJournal of Pediatric Hematology/Oncology, 1997
- The value of infusion and injection regimens in assessing efficacy and toxicity of drugsTrends in Pharmacological Sciences, 1984
- Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulationsAnnals of Biomedical Engineering, 1976
- Methotrexate in Liver and Bile after Intravenous Dosage in ManBritish Journal of Cancer, 1973